The mechanisms of how MLN4924 is effective for multiple myeloma has not been understood, but our data provide a tantalizing prospect that MLN4924 blocks neddylation of ribosomal protein such as L11, allowing vulnerability of nucleolus and activation of p53 pathway. This evidence concerns the gene RPL11 and plasma cell myeloma.